SPTY2D1 Activators
SPTY2D1 employ various biochemical mechanisms to modulate the protein's function. Forskolin, by directly stimulating adenylyl cyclase, elevates the intracellular concentration of cAMP. This increase in cAMP activates protein kinase A (PKA), which then can phosphorylate SPTY2D1, leading to its activation. Similarly, IBMX contributes to the activation of SPTY2D1 by inhibiting phosphodiesterases, thus preventing the breakdown of cAMP and indirectly fostering an environment for PKA activation. The chemical 8-Br-cAMP, a cAMP analog, diffuses into cells and mimics the action of cAMP, thereby activating PKA, which in turn can target SPTY2D1 for phosphorylation.
, PMA activates protein kinase C (PKC), which then can phosphorylate SPTY2D1. Ionomycin increases intracellular calcium levels, which can activate PKC, and subsequently, PKC may phosphorylate SPTY2D1. Okadaic acid and Calyculin A inhibit protein phosphatases, leading to a net increase in the phosphorylation state of proteins, including SPTY2D1. Epinephrine and Isoproterenol engage with adrenergic receptors to increase cAMP levels, similarly leading to PKA activation and the downstream phosphorylation of SPTY2D1. Glucagon, by binding to its receptor, triggers a cascade that also results in cAMP accumulation and PKA-mediated phosphorylation of SPTY2D1. Anisomycin activates stress-activated protein kinases, which can lead to the phosphorylation of SPTY2D1. Lastly, dibutyryl-cAMP (db-cAMP), another cAMP analog, permeates the cellular membrane and activates PKA, which can subsequently phosphorylate and activate SPTY2D1. Each of these chemicals, through their unique interactions with cellular enzymes and signaling pathways, can contribute to the phosphorylation and consequent activation of SPTY2D1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which increases intracellular cAMP by preventing its breakdown. Elevated cAMP activates PKA, which may phosphorylate and thus activate SPTY2D1. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. Once PKA is activated, it can phosphorylate SPTY2D1, resulting in the protein's activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate and activate SPTY2D1 as part of a signaling cascade. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases, such as PKC, which might then phosphorylate and activate SPTY2D1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, which could lead to increased phosphorylation levels of proteins, potentially including SPTY2D1, thereby maintaining or enhancing its activation state. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors leading to the activation of adenylyl cyclase and subsequent increase in cAMP, which activates PKA, and this kinase may phosphorylate and activate SPTY2D1. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that activates beta-adrenergic receptors, leading to increased cAMP and activation of PKA, which could then phosphorylate and activate SPTY2D1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases (SAPKs) like JNK, which could lead to the phosphorylation and activation of SPTY2D1 as part of a stress response signaling pathway. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that readily enters cells and activates PKA. Activated PKA is known to phosphorylate various proteins, which could include SPTY2D1, leading to its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 and 2A, similar to okadaic acid, and can result in the hyperphosphorylation of proteins, which may include SPTY2D1, thereby enhancing its activation state by preventing dephosphorylation. | ||||||